Send a Private Message
Follow This Member
Read Last 50 Messages
Ignore This Member
RSS Feed
Give a Gift Subscription

Search Member Posts


| Sort By: Ticker | Board | Date
Ticker  Board News Price Change Chg%   Added
ACAD  Acadia Pharmaceuticals Inc.27.1-0.2-0.73%   06/22/2017
My ACAD Pitch: "Nuplazid, the first approved treatment for Parkinson's psychosis, is now in P3 trials for schizophrenia, and in P2 as treatment for Alzheimer's psychosis, Alzheimer's agitation and for depression."
ENTA  Enanta Pharmaceuticals47.14-0.75-1.57%   01/28/2014
My ENTA Pitch: "Anti-viral drugs on the verge of, with ABBV's components, curing most strains of Hepatitis C"
HAL  Halliburton Company24.030.120.50%   01/05/2012
My HAL Pitch: "There's lots of oil and gas left in the earth's crust, but nowadays, it takes more effort to prize it out. That's where Halliburton comes in."
KKR  KKR & Co56.550.530.95%   05/18/2015
My KKR Pitch: "In a world where the Democrats have overregulated the banks, freer sources of capital such as private equity should do the best. Their high distribution is excellent source of new investment cash at times."
MCHP  Microchip Technology154.090.650.42%   01/07/2015
My MCHP Pitch: "Makes digital chip products to make cars smarter inter alia. Best dividend payer in tech."
MNTA  Momenta Pharmaceuticals, Inc.52.480.00.00%   06/22/2017
My MNTA Pitch: "Cash = $6.33 per share; through Shire's acquisition of Baxter, solely own P3-proven Humira FOB; 20 mg Copaxone copy is only approved sole generic since Q4 2015; they await approval of more popular 40 mg version in 2H 2017. M281, now in P1 is superlative agonist for circulating fcn ABs."
* Market data is delayed 15-20 minutes.

Direct Link

Consent Preferences